Kissing Disease Virus Triples Multiple Sclerosis Risk in Major Study
A common virus responsible for mononucleosis – often called the 'kissing disease' – has been found to more than triple the risk of developing multiple sclerosis, according to a significant new medical study. The research provides crucial quantification of how dangerous the combination of these two conditions can be for long-term neurological health.
The Epstein-Barr Virus Connection
Infectious mononucleosis represents the symptomatic form of Epstein-Barr virus infection, one of the most prevalent human viruses that infects approximately 95 percent of the United States population. The new research tracked nearly 19,000 individuals and discovered that children and young adults who experienced laboratory-confirmed EBV followed by symptomatic mono were substantially more likely to develop multiple sclerosis later in life compared to those who never had EBV-positive mononucleosis.
Among the more than 4,700 people with EBV-positive mono, eight progressed to develop MS – a rate more than double that observed in the uninfected control group. Multiple sclerosis currently affects about one million Americans, occurring when the immune system mistakenly attacks the protective covering of nerves in the brain and spinal cord, disrupting signals between the brain and the body.
Symptoms and Disease Progression
Multiple sclerosis symptoms typically include:
- Muscle weakness and coordination problems
- Vision loss and visual disturbances
- Numbness and tingling sensations
- Severe, debilitating fatigue
- Balance and mobility difficulties
Over time, the neurological damage can become permanent and disabling. While the exact cause of MS remains unknown, scientists believe a combination of genetic predisposition, environmental triggers, and viral infections – particularly Epstein-Barr virus – plays a critical role in disease development.
Study Methodology and Findings
Researchers conducted a population-based investigation using comprehensive medical records from the Mayo Clinic-led Rochester Epidemiology Project, which covers southeastern Minnesota and western Wisconsin. They identified 4,721 individuals who had both laboratory-confirmed EBV infection and a corresponding diagnosis code for infectious mononucleosis.
This exposed group, comprising 55 percent females and 70 percent under age 20, was matched by age and sex to three control individuals without that exposure, creating a total comparison group of 14,163 people with no evidence of EBV-positive mono during the study period.
Over approximately six to eight years of monitoring, eight people who had mono caused by EBV developed multiple sclerosis, representing 0.17 percent of that group. Among those who never had EBV-positive mono, ten individuals developed MS – just 0.07 percent of that control group.
Statistical Significance and Implications
After adjusting for factors including race, smoking history, and overall health status, researchers determined that people who had lab-confirmed EBV followed by symptomatic mono were 3.14 times as likely to develop MS as those without this viral history. The study, published in Neurology Open Access, also revealed that MS appeared sooner in the mono group – a median of 9.7 years after infection versus 14.2 years in the non-mono group.
This finding suggests that symptomatic EBV infection may not only elevate the risk of multiple sclerosis but potentially accelerate its onset. The risk of mortality remained equivalent in both groups throughout the study period.
Understanding Mononucleosis Transmission
Epstein-Barr virus primarily spreads through saliva. When teenagers experience their first exposure and develop mono, transmission typically occurs through kissing, earning the infection its colloquial nickname 'the kissing disease.' Infectious mononucleosis is extremely widespread, particularly among adolescents and young adults, with approximately 500 out of every 100,000 people in the United States contracting it annually.
Although roughly 90 to 95 percent of people carry the Epstein-Barr virus, only about one in four who are exposed actually develop noticeable symptoms of mono. The illness typically causes:
- Extreme fatigue that can persist for months
- Severe sore throat and difficulty swallowing
- Fever and general malaise
- Swollen lymph nodes in the neck and armpits
Many individuals also experience swollen tonsils with white patches, headaches, body aches, and an enlarged spleen that can rupture if the person engages in contact sports or heavy lifting too soon after infection.
Important Distinctions and Limitations
It is crucial to understand that while people with EBV-positive mono are three times more likely to develop MS, this does not establish that mono directly causes multiple sclerosis. The study identified a strong statistical association – a significant correlation – but not definitive proof of cause and effect.
Nearly all individuals with multiple sclerosis show evidence of past EBV infection – over 99 percent compared to approximately 90 to 95 percent of the general population. However, the overwhelming majority of people who contract EBV, including those who become ill with mononucleosis, will never develop multiple sclerosis.
Medical experts emphasize that these findings, derived from comprehensive population-based research, highlight the urgent need for preventive strategies, including potential EBV vaccine development, to reduce the long-term burden of this devastating neurological disease.
